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There are few studies on the neuropharmacological properties of asparagus, which was applied in Chinese traditional medicine
as a tonic and heat-clearing agent. The present study was designed to investigate the anxiolytic-like activity of the aqueous extract
of asparagus stem (AEAS) using elevated plus maze (EPM) and Vogel conflict tests (VCT) in mice. AEAS significantly increased
the percentage of time spent in open arms in EPM, when compared with control group. In the Vogel conflict drinking test, the
n u m b e r so fp u n i s h e dl i c k si n c r e a s e dt o1 7 7 %a n d1 7 4 %b yt h et r e a t m e n to fA E A Sa tt h ed o s e so f1 . 5a n d3 . 0g / k g( 2 5 0a n d5 0 0m g
sarsasapogenin per kilogram of body weight), compared with control group. The serum cortisol level decreased significantly, at
the same time. In conclusion, these findings indicated that the aqueous extract of asparagus stem exhibited a strong anxiolytic-like
effect at dose of 1.5 and 3.0g/kg (250 and 500mg sarsasapogenin per kilogram of body weight) in experimental models of anxiety
and may be considered an alternative approach for the management of anxiety disorder.
1. Introduction
Anxietyandrelateddisorders,mostcommonmentalillnesses
worldwide, represent a prominent healthcare problem [1–4].
ReportsfromtheWorldHealthOrganization(WHO)suggest
that anxiety and related disorders will become the second
leading cause of disability in both developed and developing
countries by the year 2020 [5]. Benzodiazepines are among
the first line of drugs that have been extensively used to
treat several forms of anxiety [6]. Although benzodiazepines
havewell-knownbenefits,theirsideeffectsareprominent[7].
Therefore, the search for new therapeutic agents continues.
Interest in alternative medicine and plant-derived functional
food to conquer stress and promote relaxation has increased
recently. For example, the concept of a relaxation drink first
emerged in Japan in 2005 [8].
Asparagus officinalis L., a well-known nutritious and
healthy vegetable, was applied widely in the traditional
Chinese medicine clinic practice, as a tonic, heat-clearing,
antitussive,anddiureticagent.Inrecentyears,varioushealth-
ful effects of the asparagus have been scientifically verified
[9–13]. Asparagus industrial product development is in the
ascendant, in China. In early 2013, the Chinese government
authorizedtheaqueousextractofasparagusstem(AEAS)asa
natural functional food and beverage ingredient. The present
study investigated the potential anxiolytic effect of AEAS in
mice.
2. Materials and Methods
2.1. Plant Material. Material was collected from cultivation
in Hangu administration zone of Tangshan, a vegetation
zone that belongs to Qinhuangdao Changsheng Agricultural
Technology Development Co., Ltd. Botanical samples were
identified by Professor Peng of Hebei Normal University of
Science and Technology, Qinhuangdao, China.2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: The chromatography of sarsasapogenin from AEAS.
2.2. Extract Preparation. Aqueous extract from the stem
of Asparagus officinalis L. was provided by Qinhuangdao
ChangshengAgriculturalTechnologyDevelopmentCo.,Ltd.,
Hebei Province, China. To obtain the aqueous extract from
the woody stem of asparagus, fresh plant material (60.0kg)
wascleaned,crushed,andthenextractedwithdrinkingwater
(plant/water ratio 1:8 w/v; water temperature: 85 ± 5
∘C) by
dynamic maceration for 5h. After filtering, the solution of
asparagus stem was treated with spray drying to dryness,
yielding extract powder (1.0kg AEAS).
2.3. Extract Character. The nutrient and chemical compo-
nents of this studied extract were identified and quanti-
fi e d( s h o w ni nTable 1). Amino acid composition analysis
was performed by a fully automatic amino acid analyzer
(Hitachi L-8900, Japan). The data were shown in Table 2.
The main biologically active constituents of asparagus are
the steroidal saponins and flavonoids. For quantitative deter-
mination of the steroidal saponins, the AEAS was refluxed
with hydrochloric acid solution. The sarsasapogenin from
asparagus was determined by reversed phase high perfor-
manceliquidchromatographicmethodwithevaporativelight
scattering detection (RP-HPLC-ELSD) (shown in Figure 1).
The content of sarsasapogenin was 17.80%. The fingerprint
of the flavonoids from AEAS was established by HPLC-UV
(shown in Figure 2 and Table 3). Asparagus extract solution
was mixed with diethyl ether then stirred. The diethyl ether
layer was separated and evaporated to dryness. The resulting
residue was dissolved in methanol as sample solution for
fingerprint analyses.
The analyses were performed using a Zorbax C18 column
and a diode array detector in an Agilent1100 HPLC system.
The mobile phase was 0.5% formic acid solution (solvent A)
and methanol (solvent B), at a flow rate of 0.7mL/min. The
gradientelutionwas0–20min,80%–70%A,20%–30%B,20–
45min, 70%–60% A, 30%–40% B, 45–60min, 60%–50% A,
40%–50% B, 60–70min, 50%–30% A, 50%–70% B, and 70–
75min, 30%–0% A, 70%–100% B. The UV detector wave-
length was set at 320nm. Five compounds were identified by
Table 1: Nutrient and chemical compositions of the AEAS.
No. Compositions Content Unit
1 Carbohydrates 44.4 g/100g
2 Proteins 24.5 g/100g
3 Lipids 3.0 g/100g
4 Calcium 3.84 g/100g
5P o t a s s i u m 1 . 1 2g / 1 0 0 g
6 Magnesium 0.33 g/100g
7 Sodium 0.28 g/100g
8 Ferrum 0.06 g/100g
9 Copper 0.19 g/100g
10 Zinc 0.09 g/100g
11 Vitamin E 0.17 mg/100g
12 Vitamin B1 0.39 mg/100g
13 Vitamin B2 0.89 mg/100g
14 Selenium 0.14 mg/100g
15 Saponins 17.80 g/100g
16 Flavone 2.91 g/100g
17 Polyphenol 5.93 g/100g
18 Polysaccharide 11.21 g/100g
19 GABA 0.82 g/100g
AEAS: aqueous extract of asparagus stem; GABA: gamma-aminobutyric
acid.
the spectral feature of UV, MS, and MS/MS, (Table 3). The
main 8 peaks were quantified by comparing their peak areas
with the refer substance (Peak 1).
2.4. Drug. Distilled drinking water was used as vehicle.
Diazepam(DZP)wasusedasthereferencedrugforanxiolytic
activities.
2.5. Animals. Male Imprinting Control Region mice (CD-
1, ICR, 18∼22g) were purchased from Beijing Vital River
LaboratoriesCo.,Ltd.(Beijing,China).Animalswerehoused
in a controlled environment (temperature 23
∘ ±2
∘C, relativeEvidence-Based Complementary and Alternative Medicine 3
Table 2: Amino acid analyses of the AEAS.
No. Amino acid Content (g/100g)
1A S P 5 . 9 5
2 THR 0.29
3 SER 0.51
4 GLU 4.77
5 GLY 0.51
6 ALA 0.48
7 VAL 0.53
8 MET 0.07
9 ILE 0.16
10 LEU 0.41
11 TYR 0.23
12 PHE 0.15
13 LYS 0.29
14 HIS 0.11
15 ARG 0. 41
16 PRO 2.60
17 TRP 0.11
18 CYS 0.28
19 Total 17.86
AEAS: aqueous extract of asparagus stem.
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Figure 2: The HPLC-UV fingerprint of the flavonoids from AEAS.
humidity 50% ± 10%, 12h light/dark cycle) and allowed free
access to standard diet. They were acclimatized for 5 days
prior to the initiation of the test.
Fortherepeateddosetoxicitystudy,SpragueDawley(SD)
rats were used. The rats were housed in stainless steel cages,
kept under controlled conditions of temperature (23 ± 2
∘C),
relative humidity (55 ± 10%) and ventilation (more than 10
times/hour) with a 12-hour light/dark cycle, and allowed free
access to food and water throughout both the acclimation
andexperimentationperiods.Allanimalsweremaintainedin
accordancewiththeBeijingLaboratoryAnimalManagement
Regulations.
2.6.ElevatedPlusMaze. Evaluationofthepossibleanxiolytic
effectwasperformedaccordingtothepreviousliterature[14–
16]. Shanghai Manpu Biotechnology Co., Ltd., furnished the
EPM apparatus (mode: RD1108-EPM-M), which comprised
two open (30cm × 5cm) and two closed arms (30cm ×
5cm×15cm)thatextendedfromacommoncentralplatform
(5cm×5cm).Topreventmicefromfallingoutofthemaze,a
ledge(2mmH)surroundedtheopenarms.Thefloorandthe
w a l l so fe a c ha r mw e r ep a i n t e db l a c k .Th ee n t i r em a z ew a s
elevated 60cm above floor.
Experiments were conducted in a dimly lit, quiet room.
Wepretreatedmalemiceorallywithvehicleordifferentdoses
(0.6, 1.5, or 3.0g/kg) of AEAS (equivalent to 100, 250, and
500mg sarsasapogenin per kilogram of body weight) 30min
before placing them on the EPM. One group of animals
receiveddiazepam(3mg/kg,p.o.)asreferencedrug.Tobegin
a test session, mice were placed in the center of the maze
facing one of the open arms and allowed to walk freely for
5min.Aftereachtrial,themazewaswipedcleanwithadamp
sponge and dried with paper towels. All the tests were
recorded by video camera.
Entry into an arm was defined as the animal placing all
four paws over the line marking that area. Standard spa-
tiotemporal measures were scored: the number of entries in
theopenandtheclosedarms,thetotalnumberofarmentries,
andthetimespentinthedifferentpartsofthemaze(openand
c l o s e da r m s ) .Th er a t i oo fo p e na r me n t r i e sa n dc l o s e da r m
entries to the total number of arm entries was also calculated
during a 5min test period for each animal.
2.7. Vogel Conflict Test. Mice were habituated for 5 days
and then divided randomly into five groups. Control group
animals received drinking water only. DZP group received
3.0mg/kg of diazepam (p.o.). AEAS groups received 0.6, 1.5,
or 3.0g/kg AEAS (equivalent to 100, 250, and 500mg sarsas-
apogenin per kilogram of body weight) per day, respectively.
This procedurecontinuedfor 7 days. At 8:30 am of day 8, rats
were treated with AEAS, DZP, or drinking water. The Vogel
conflict test was performed about 30min later.
The Vogel conflict test apparatus (mode: AES-340, Ani-
Lab Software and Instruments Co., Ltd.) was applied, essen-
tially using the procedure originally described by Vogel et al.
[17]. The VCT was performed in a Plexiglas box with a stain-
less steel grid floor. The metallic spout of a drinking bottle
thatcontainedwaterprojectedintothebox.Thesimultaneous
contactoftheanimalwiththespoutandthegridfloorclosed
an electrical circuit controlled by a sensor, producing seven
pulses of water per second whenever the animal was in con-
tactwithbothcomponents.Eachpulsewasconsideredalick.
After every 20 licks, the animal received a 0.5mA footshock
for 2s. The sensor recorded the total number of licks and
shocks delivered during the test period. The entire apparatus
waslocatedinsideasound-attenuatedcage.Aftercompleting
thetestsession,allratswereanesthetized.Thefemoralarterial
b l o o dw a sc o l l e c t e da n dc e n t r i f u g e dt og e ts e r u ms a m p l e .
Their brains were rapidly dissected (not more than 3min)
on ice, then hippocampus were dissected, weighed, and
homogenized in 0.1M phosphate buffer solution by manual
homogeniser,centrifugedat10,000rpmfor20mintoremove
supernatant and stored at −20
∘Cu n t i la n a l y s i s .
2.8. Neurochemical Assay. The cortical levels in serum
weredeterminedbycommerciallyavailableradioimmunoas-
say kits (Beijing North Institute of Biological Technol-
ogy Co., Ltd., Beijing, China). Catecholamine (epinephrine,4 Evidence-Based Complementary and Alternative Medicine
Table 3: The spectrum data of the AEAS.
No. UV (nm) MS MS/MS Chemical name Relative peak area
1 270nm 595 [595]: 331 (100), 535 (19.65), 287 (8.19) Kaempferol-3-O-𝗽-rutinoside 1.00
2 270nm 268 [268]: 136 (100) 7-hydroxy-4
򸀠-methoxyisoflavone 0.08
33 3 0 , 2 6 0 6 1 1 [611]: 591 (100), 467 (38.97) Rutin 0.65
43 4 0 , 2 6 0 3 1 7 [317]: 298 (84), 198 (100) Isorhamnetin 0.72
53 2 0 , 2 8 0 3 0 1 [301]: 269 (100), 241 (99) Quercetin 0.67
6 0.63
7 0.46
8 0.33
norepinephrine, and dopamine) and 5-hydroxytryptamine
(5-HT) levels in serum and tissue homogenate were deter-
mined by enzyme immunoassay kits (Cusabio Biological
Technology Co., Ltd., Wuhan, China).
2.9. Repeated Doses Toxicity. For evaluation of the edible
safety, 13 weeks repeated dose oral toxicity study was per-
formed in rats. SD rats were assigned into four groups ran-
domly: Group I: control group; Group II: treated with AEAS
1.25g/kg (equivalent to 208mg sarsasapogenin per kilogram
of body weight); Group III: treated with AEAS 2.50g/kg
(equivalent to 417mg sarsasapogenin per kilogram of body
weight); Group IV: treated with AEAS 5.00g/kg (equivalent
to 835mg sarsasapogenin per kilogram of body weight). The
doses were designed according to the previous acute study
result and the recommended daily dose (equivalent to 25-,
50-, and 100-fold of recommended dose, 3.0g/d for adult).
Ratgrossbehavior,mortality,bodyweightgain,andfood
intake were recorded throughout the repeated treatment.
After13weeksfeeding,allratsweredeprivedoffood(butnot
water) overnight and then were anesthetized. The urine and
blood sample were collected then detected, respectively. The
organs (liver, kidneys, adrenal glands, spleen, lungs, heart,
brain, and so forth) were harvested, weighed, and then pro-
cessed for histopathological examination. Hematological
examination was carried out by an automatic analyzer
(Hitachi 7600-010, Hitachi Co., Hyogo, Japan). The urine
analyses were performed with urinalysis strips (Suzhu phar-
m a c e u t i c a lC o . ,L t d . ,J i a n g s u ,C h i n a ) .
2.10. Statistical Analysis. Data were processed to give group
mean values and standard deviations. The quantitative data
were assessed by one-way analysis of variance (ANOVA).
If the F distribution was significant, a t-test was used to
specify differences between groups. 𝑃 < 0.05 was considered
statistically significant. The SPSS 11.0 software package (SPSS
Inc., Chicago, IL, USA) was used for the statistical test.
3. Results
3.1. Effect of AEAS in EPM Test. The one-way ANOVA
revealed a significant increase in the percent of time spent in
open arms with AEAS treatment (1.5 and 3.0g/kg) compared
with the control (Figure 3). AEAS treatment increased the
ratio between the number of entries in open arm and total
entries,butthesechangeswerenotstatisticallysignificant.No
differences were observed in total arm entries. As expected,
DZP treatment yielded a significantly increased percent of
open arm entries and time spent in open arms.
3 . 2 .E ff e c to fA E A Si nV o g e lT e s t . To confirm the anxiolytic-
likeeffectofAEAS,theVogelconflicttestwasapplied.Inthis
experiment, one-way ANOVA revealed significant variance
among the five groups. Doses of 1.5 and 3.0g/kg significantly
increased the number of punished licks compared with
controls(Figure 4).Asexpected,DZP(3mg/kg)significantly
increased the number of punished licks.
3.3. Neurochemical Assay. In the Vogel conflict test, the
serum cortisol and epinephrine level increased signifi-
cantly, compared with the control (Figure 5). AEAS treat-
ment resulted in decreasing levels of serum cortisol. How-
ever, AEAS treatment produced an opposite effect on 5-
HT, increasing the serum 5-HT level. Epinephrine levels
d e c r e a s e di nA E A S -a n dD Z P - t r e a t e dg r o u p s ,w i t hn o
statistical significance, compared with the model group.
We observed no significant changes in norepinephrine and
dopamine levels between these groups.
The levels of epinephrine, 5-HT, norepinephrine, and
dopamine in hippocampus homogenate showed no signifi-
cant changes between groups (data not shown).
3.4. Repeated Doses Toxicity. All rats survived for the dura-
t i o no ft h ef e e d i n gt r i a l .Th e r ew e r en on o t a b l ec h a n g e si n
behavior,activity,posture,gait,orexternalappearanceinany
of the groups. There was no significant difference in average
body weights or average daily food intakes between the rats
in the control group and those in any of the treated groups
during the study (for both sexes). All animals were subjected
tocompletenecropsy.Fortherelativeorganweight,statistical
analysis result showed that there was no difference between
groups (Table 4). The qualitative analyses of urobilinogen,
urine glucose, urine acetone bodies, urobilinogen, urine
protein, and urine nitrite were negative. The urine pH was
in normal range in both of the control group and treated
groups. As shown in Table 5, there was no significant adverse
effect in any of the treated groups, compared with control
group. Serum biochemistry results (Table 6) demonstrated
that the parameters of biochemistry were within the normal
range, and statistical analysis results showed that there was
no difference between groups. In the histopathological study,Evidence-Based Complementary and Alternative Medicine 5
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Figure3:TheeffectofAEASontheEPMtestinmice((b)forOE%and(a)forOT%).Theaqueousextractofasparagusstem(AEAS),elevated
plus maze (EPM), and diazepam (DZP). The percent of open arm entries to the total number of arm entries (OE). The percent of time spent
in the open arm to the total time in the open and close arms (OT). The dose of aqueous extract of asparagus stem 0.6g/kg (AEAS-L). The
dose of aqueous extract of asparagus stem 1.5g/kg (AEAS-M). The dose of aqueous extract of asparagus stem 3.0g/kg (AEAS-H).
∗𝑃 < 0.05
statistically significant difference from control.
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Figure4:TheeffectofAEASontheVogelconflicttest.Theaqueous
extractofasparagusstem(AEAS)anddiazepam(DZP).Thepercent
of open arm entries to the total number of arm entries (OE). The
percent of time spent in the open arm to the total time in the open
and close arms (OT). The dose of aqueous extract of asparagus stem
0.6g/kg (AEAS-L). The dose of aqueous extract of asparagus stem
1.5g/kg (AEAS-M). The dose of aqueous extract of asparagus stem
3.0g/kg (AEAS-H).
∗𝑃 < 0.05 statistically significant difference
from control.
there were no treatment-related changes in the main organs
(for both sexes), whereas only sporadic and/or spontaneous
lesions were observed similarly in the control and treated
animals. The current study indicates no observable adverse
effects on the rat reproductive system.
4. Discussion
The literature survey revealed that the steroidal saponins are
the main biologically active constituents of Asparagus. In the
previous pentobarbital-induced sleep test, linear regression
analysis showed a correlation between asparagus saponin
intake and increased sleeping time. Reports suggest that
sarsasapogeninfromAnemarrhenaasphodeloidesBunge(Lil-
iaceae) exile antidepressant activity by mediation of the cen-
tral monoaminergic neurotransmitter systems [15, 16]. The
contentofsteroidalsaponinswasquantifiedbydetermination
of sarsasapogenin, as an index of active constituents of
asparagus.
Thepresentstudysoughttoanalyzethebehavioraleffects
ofAEASintwoanimalmodels.TheresultsshowedthatAEAS
exhibited anxiolytic-like activity and mediated the secretion
of cortisol and 5-HT. The neurochemical assay suggested
that the anxiolytic effects of AEAS may be partly attributable
to the modulation of neuronal and endocrine. The present
findings may also provide important scientific evidence for
the application and development of relaxation functional
food to conquer the anxiety.
The elevated plus maze is one of the most widely used
modelsandhasbeenvalidated[18,19],whichusesthenatural
fear of rodents to avoid open and elevated places. When the
animals were treated with the higher doses of AEAS (1.5 and
3.0g/kg), anxiety-like behavior in the elevated plus maze was
significantly attenuated, increasing the percent of time spent
in open arms.
The Vogel test has become a standard for fast screening
the potential anxiolytic properties of drugs. In this pro-
cedure, drinking behavior is punished by mild electrical
shocks,leadingtosignificantlyreducedwaterconsumptionin
deprivedanimals.Tofurthervalidatethesedata,wetestedthe
anxiolytic-like effects of these treatments in the VCT, which
involves the suppression of punished responses. The behav-
ioral suppression induced by shocks in the VCT is atten-
uated by anxiolytic drugs. The doses of 1.5 and 3g/kg
AEAS increased the number of punished licks (i.e., induced
anxiolytic-likeeffects)to177%and174%.Inthepresentstudy,
diazepam was used as a positive control. As expected, it
increased activity in the open arms of the elevated plus maze6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: The serum biochemical levels in the Vogel conflict test ((a) for CROT and (b) for 5-HT). The aqueous extract of asparagus stem
(AEAS) and diazepam (DZP). The percent of open arm entries to the total number of arm entries (OE). The percent of time spent in the
open arm to the total time in the open and close arms (OT). The dose of aqueous extract of asparagus stem 0.6g/kg (AEAS-l). The dose of
aqueous extract of asparagus stem 1.5g/kg (AEAS-m). The dose of aqueous extract of asparagus stem 3.0g/kg (AEAS-h), Cortisol (CORT),
and 5-Hydroxytryptophan (5-HT).
∗𝑃 < 0.05 statistically significant difference from control;
#𝑃 < 0.05 statistically significant difference
from model.
and number of punished licks in the VCT, confirming its
anxiolytic actions.
As traditional medicine spreads extensively worldwide,
edible herbs have become an increasingly important ingredi-
ent in functional foods and therapeutic drugs. In India, tra-
ditional folk medicine uses the roots of Asparagus officinalis
L. to promote improvement in physical and mental health
[11–13]. Component analysis showed that asparagus are rich
in saponins from Asparagus officinalis (17.8%), aspartic acid
(6.1%, accounting to one third of total amino acid), and
gamma-amino butyric acid (1.0%). Aspartic acid is an amino
acid that participates in hormone production and nervous
systemfunction.Specifically,asparticacidcontributestofight
fatigueandothersymptomsrelatedtostaminadeficiency.The
brain converts glutamine into glutamic acid and increases
the amount of gamma-aminobutyric acid (GABA), which is
needed to sustain proper brain function and mental activity
[20, 21]. Naturally existing GABA in AEAS also participates
importantly in relieving stress and exhibiting anxiolytic
effect.
For the edible safety investigation, the acute toxicology
study suggesting the maxim tolerant dose was 20.0g/kg in
this experiment condition. In the repeated dose oral toxicol-
ogy study, the safety dose was 5.0g/kg for 13 weeks.
In summary, the present study showed that AEAS exhib-
ited strong anxiolytic-like effect and mediated the secretion
of crotisol and 5-HT. These data demonstrated that acute
stress (open elevated plus maze and punished licks) [22]
elicits anxious behaviors and increases serum cortisol level.
TheAEAStreatmentwhichdecreasesthesecretionofcrotisol
suggested that the anxiolytic effect of AEAS may be partly
attributable to the modulation of neuronal and endocrine.
Therefore, AEAS is a promising candidate for the treatment
of anxiety-like disorders in the alternative medicine.
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